RGS16 and pancreatic neoplasm: For example, in patients with pancreatic cancer with lymph node metastasis, the RGS16 and FosB expression is markedly reduced in pancreatic cancer andis closely associated with a decreased survival rate of patients (Kim et al., 2010).